$PBIO Pressure BioSciences to Participate in the B
Post# of 98055
https://www.accesswire.com/670731/pressure-bi...stor-event
Company Invites Individual and Institutional Investors, as well as Analysts and Advisors, to Attend Its Live, Virtual Guest Appearance on Thursday, November 4, 2021
SOUTH EASTON, MA / ACCESSWIRE / November 2, 2021 / Pressure BioSciences, Inc. (OTCQB BIO) ("PBI" and the "Company" , a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables, and services to the worldwide life sciences, agriculture, food & beverage, and other key industries, today announced the Company's participation in Benzinga's November 4th ALL ACCESS Investor Event. This real-time, virtual event will feature up to 12 companies in a unique, first-of-a kind format that effectively comingles part interview, part investor presentation. PBI's President and CEO, Mr. Richard T. Schumacher, has been invited to participate on the show:
DATE: Thursday, November 4, 2021
TIME: 11:20 am ET
PRESENTATION: Live, Virtual
LINK TO VIEW: Click Here
Recent Company Highlights
Reported resurgent growth with our strongest financial half in three years.
Offered guidance that we expect even stronger financial results for Q3/Q4 2021.
Expect to acquire assets of global eco-friendly agrochem supplier with major Q3/Q4 2021 revenue impact.
Our patented UST™ platform processed Neem Oil into a highly potent, stable, and safe insecticide.
Announced the formation of a food industry Consortium with our partner Ohio State University.
Reported plans to set-up Toll Manufacturing Partnerships on the east and west coasts of the U.S.
Awarded four additional patents for our novel, proprietary UST platform.
Reported that UST-processed CBD oil nanoemulsions exceeded an unprecedented 12 months of stability.
Reported the UST Platform successfully processed Astaxanthin - the world's most powerful antioxidant.